1. Introduction
===============

Scoliosis is the bony structural deformity characterized by coronal, lateral, and rotational curvature of spine that may be associated with dysfunction of the neuromuscular system (neuromuscular scoliosis), transformation of soft tissue (systemic syndromes), disturbance of neural metabolism (neurofibromatosis), abnormal formation of vertebrae and thorax (congenital deformity), and other issues.^\[[@R1]\]^ The prevalence of idiopathic scoliosis is approximately 2% to 3% worldwide^\[[@R2]\]^ and is thought to be the most common type of scoliosis. Adolescent idiopathic scoliosis (AIS) is a common form that affects approximately 80% to 90% of the spinal deformity population, is prevalent in 1% to 4% of individuals aged 10 to 18 years, and has a great impact on children\'s physical and psychological health.^\[[@R3],[@R4]\]^ There is an established correlation between curve progression and the age of the child.^\[[@R5],[@R6]\]^ AIS is found in early puberty with rapid growth until sexual maturity, and females have a higher incidence rate and more aggravated spinal curves. It is well known that there is rapid curve progression in AIS children following diagnosis with AIS in adolescence. Thus, some researchers believe that the regulation of hormones during the adolescent period might be correlated with spinal curve initiation and progression.^\[[@R7],[@R8]\]^ As AIS has a strong influence on patients' physical and psychological condition and social burdens, early diagnosis and suitable therapy are essential to prevent curvature deterioration.

The etiology and pathogenesis of AIS remain poorly understood, despite numerous studies. However, no studies have exactly illustrated the etiology of scoliotic formation. In recent years, many pathogenetic factors have been found to be potential contributors to susceptibility to AIS, including heritage and genetic factors,^\[[@R9],[@R10]\]^ environment,^\[[@R11]\]^ and low bone mineral density (BMD).^\[[@R12],[@R13]\]^ In addition, different mechanisms have been revealed, such as bone growth, aberrant musculoskeletal system, neurological system defects, and metabolism abnormalities.^\[[@R7],[@R14],[@R15]\]^ However, the exact etiology and mechanisms of scoliotic progression remain unclear.

In recent years, many studies have focused on the roles of genes and genetic polymorphisms in the etiology and development of AIS. Several reports with multiple twin series have suggested a higher concordance in monozygotic twins than in dizygotic twins.^\[[@R16]\]^ One study reported that 15% of families presented with a locus on the X chromosome that could be connected to X-linked dominant inheritance among familial idiopathic scoliosis patients.^\[[@R17]\]^ Other genetics-related studies demonstrated that some chromosomes and gene polymorphisms had strong correlations with the susceptibility to AIS, including chromosomes 6, 9, 16, and 17.^\[[@R18]--[@R20]\]^ In addition, more gene polymorphisms have been found to be significantly associated with the etiology and development of AIS. Nikolova et al^\[[@R21]\]^ performed a case--control study in Bulgarian patients and found significant relationships between an interleukin-6 (IL-6, rs1800795) polymorphism and the susceptibility to IS and the severity of curve deformation, suggesting that the *IL-6* gene polymorphism could be a susceptibility and modifying factor for IS. Another study in a Chinese population revealed that the CC genotype of the boron neutron capture synovectomy (BNCS) rs10738445 polymorphism was found with higher frequency in AIS cases than in controls, and there was a significant correlation with the magnitude of curves.^\[[@R22]\]^ In addition, a meta-analysis showed that the rs11109087, r678741, and rs625039 polymorphisms of the ladybird homeobox 1 (*LBX1*) gene were important contributors to AIS susceptibility in some populations.^\[[@R23]\]^ Candidate gene approaches and genome-wide association studies (GWAS) have also suggested that there is a network relationship between different genes such as IL-6, estrogen receptor 1 (ESR1), estrogen receptor 2 (ESR2), vitamin D receptor (VDR), transforming growth factor beta 1 (TGFB1), and insulin-like growth factor 1 (IGF1) in the etiology and development of AIS.^\[[@R24]\]^

As is known, the *VDR* gene encodes for a nuclear receptor for vitamin D metabolites and is located on chromosome 12q12-q14.^\[[@R24],[@R25]\]^ It has been well established that VDR is an important contributor to the biological function of vitamin D, and it plays an important role in the regulation of BMD and skeletal metabolism and development. In addition, previous studies have shown strong relationships between VDR polymorphisms and some kinds of bone disorders, such as osteoarthritis and osteoporosis.^\[[@R26],[@R27]\]^ Due to the key roles of VDR in the etiology and development of many diseases and the potential impact of gene polymorphisms and hormones in AIS etiology, more studies have been performed to explore the relationships between VDR and AIS etiology.^\[[@R24],[@R28]--[@R30]\]^ The *VDR* gene polymorphisms, FokI, BsmI, and Cdx2, are considered key contributors to AIS etiology, and BsmI might play an important role in BMD.^\[[@R24],[@R25],[@R31]\]^ Several studies demonstrated that the frequencies of the BsmI B allele and Bb genotype in AIS were higher than those in control cases in Asian populations.^\[[@R29],[@R31]--[@R33]\]^ However, other studies have shown no association between the ApaI A or a allele and the clinical characteristics of AIS patients.^\[[@R29],[@R32],[@R33]\]^ Due to these conflicting results, we performed this review and systemic meta-analysis to determine whether there were significant relationships between the VDR BsmI rs1544410 and ApaI rs7975232 polymorphisms and AIS risk.

2. Methods
==========

2.1. Literature search
----------------------

This study was approved by the ethics committee of our hospital (First Affiliated Hospital of PLA General Hospital, Beijing). Databases, including PubMed, EMBASE, Web of Science and the Cochrane Library, the Chinese Biomedical Literature database, and the Wanfang database, were searched for case--control studies that focused on the relationships between the BsmI (rs1544410) and ApaI (rs7975232) polymorphisms and susceptibility to AIS. The following search terms were used: ("adolescent idiopathic scoliosis" OR "AIS") AND ("vitamin D receptor" OR "VDR") AND ("polymorphism" OR "single nucleotide polymorphism" OR "SNP" OR "variation"). AIS is defined by lateral curvature of the spine in children aged between 10 and 16 years with a Cobb angle of at least 10°. In all included studies, the definition of AIS and individuals recruited in these studies were identified with these parameters. Then, studies were selected that involved the association between the BsmI rs1544410 or ApaI rs7975232 polymorphisms and AIS.

No language restrictions were applied during the literature search. Secondary screens of unpublished literature were conducted by searching the reference lists of the selected studies and reviews. Reviews and comments were also examined to identify eligible studies.

2.2. Inclusion and exclusion criteria
-------------------------------------

The inclusion criteria of our meta-analysis were as follows: case--control study; evaluation of AIS risk and at least 1 of the 2 identified gene polymorphisms (BsmI rs1544410 or ApaI rs7975232); and sufficient data, including number or frequency of alleles and genotypes. The exclusion criteria were as follows: reviews or case reports that were not case--control studies; no available data reported; and duplicated reports.

3. Data extraction
==================

Data from the eligible studies were extracted according to the inclusion and exclusion criteria by 2 authors, and a consensus was reached. For each study, the following data were collected: author list, year of publication, ethnicity, sample size, alleles, and genotypes of BsmI rs1544410 or ApaI rs7975232 polymorphisms.

The odds ratio (OR) and 95% confidence interval (CI) were calculated to evaluate the association between the BsmI rs1544410 polymorphism and AIS. An allele contrast model (B vs b), heterozygote model (Bb vs bb), homozygote model (BB vs bb), dominant model (BB/Bb vs bb), and recessive model (BB vs BB/Bb) were examined for the BsmI rs1544410 polymorphism. The strength of association between the ApaI rs7975232 polymorphism and AIS susceptibility was evaluated by OR and 95% CI according to the allele contrast model (A vs a), heterozygote model (Aa vs AA), homozygote model (aa vs AA), dominant model (Aa/aa vs AA), and recessive model (AA vs Aa/aa). The assumption that there was heterogeneity was verified by a Chi-squared based Q statistical test and quantified by the *I*^2^ metric value. If the *I*^2^ value was \>50% or *P* \< .10, suggesting obvious heterogeneity, ORs were pooled by the random effect model. Otherwise, the fixed effect model was used. Sensitivity analysis was performed to assess the impact of each study on the combined effect of the present meta-analysis and subgroup analysis according to the ethnicity of the study populations. All meta-analyses were performed using Stata 12.0 software (StataCorp, College Station, TX), and a *P* value below .05 indicated statistical significance. Power analysis was performed using the Power and Precision V4 software (Biostat Inc, Englewood, NJ).

4. Results
==========

4.1. Study characteristics
--------------------------

We searched all the common databases, including PubMed, EMBASE, Web of Science, the Cochrane Library, the Chinese Biomedical Literature database, and the Wanfang database, to find all eligible studies that investigated the relationships between the BsmI (rs1544410) and ApaI (rs7975232) polymorphisms and susceptibility to AIS. We found 6 studies that could be included in our meta-analysis. The data in 1 study were not available, and the authors only reported their conclusions. We attempted to obtain the data by contacting the corresponding author but received no response. Therefore, we excluded this study. In the end, a total of 5 studies^\[[@R29],[@R31]--[@R34]\]^ with 717 cases and 544 controls met the selection criteria and were included in our study. Four studies^\[[@R29],[@R31]--[@R33]\]^ were performed in Asian populations, and 1 study^\[[@R34]\]^ focused on a Caucasian population. Each study^\[[@R29],[@R31]--[@R34]\]^ included the genotype distribution detail for the BsmI B/b polymorphism, and 3 studies^\[[@R29],[@R32],[@R33]\]^ included genotype distribution for ApaI A/a. The study selection and inclusion process are presented in Fig. [1](#F1){ref-type="fig"}. The general demographic characteristics of the subjects in this meta-analysis are summarized in Table [1](#T1){ref-type="table"}. Before this meta-analysis was performed, a power analysis was conducted by using Power and Precision V4 software to verify whether the included studies could offer adequate power (\>80%). The statistical power in our study was sufficient to detect the associations between *VDR* gene polymorphisms and AIS risk.
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###### 

General characteristics of studies included in the meta-analysis.
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4.2. Meta-analysis results
--------------------------

This meta-analysis showed a significant correlation between the BsmI rs1544410 polymorphism and the risk of AIS in several genetic models in the overall population (B vs b: OR = 2.12, 95% CI = 1.21--3.75, *P* = .009; BB vs bb: OR = 3.38, 95% CI = 1.08--10.57, *P* = .036; Bb vs bb: OR = 2.50, 95% CI = 1.29--4.82, *P* = .006; BB/Bb vs bb: OR = 2.71, 95% CI = 1.31--5.63, *P* = .007), as indicated in Table [2](#T2){ref-type="table"} and Fig. [2](#F2){ref-type="fig"}. In addition, the results of subgroup analysis indicated a significant association between the BsmI rs1544410 polymorphism and AIS susceptibility in the Asian population (B vs b: OR = 2.42, 95% CI = 1.27--4.61, *P* = .007; BB vs bb: OR = 4.09, 95% CI = 1.03--16.22, *P* = .045; Bb vs bb: OR = 2.94, 95% CI = 1.32--6.10, *P* = .004; BB/Bb vs bb: OR = 3.23, 95% CI = 1.42--7.35, *P* = .005), but no significant association was observed in the Caucasian population (Table [2](#T2){ref-type="table"}, Fig. [3](#F3){ref-type="fig"}).

###### 

Results of genetic models for BsmI polymorphisms and adolescent idiopathic scoliosis.
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![Forest plot describing the meta-analysis under the heterozygote model for the association between BsmI rs1544410 B/b polymorphism and AIS risk (Bb vs bb).](medi-97-e9627-g004){#F2}
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Regarding the ApaI rs7975232 polymorphism, the results indicated a stronger association with AIS risk in two genetic models in the Asian populations (Aa vs AA: OR = 0.43, 95% CI = 0.24--0.77, *P* = .004; Aa/aa vs AA: OR = 0.52, 95% CI = 0.30--0.91, *P* = .023), as indicated in Table [3](#T3){ref-type="table"}, Figs. [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}. However, whether the ApaI rs7975232 polymorphism plays a key role in AIS etiology in either Caucasian populations or the overall population remains unclear, as no articles studying the relationship between the ApaI rs7975232 polymorphism and AIS risk were found in our database search.

###### 

Results of genetic models for ApaI polymorphisms and adolescent idiopathic scoliosis.
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4.3. Sensitivity analysis and publication bias
----------------------------------------------

The corresponding pooled results did not change dramatically when each study was removed. Therefore, all these results were of high stability, and we can conclude that our meta-analysis data are relatively stable and credible. We did not evaluate publication bias because it might be difficult to assess this when fewer than 10 studies were included.

5. Discussion
=============

Multiple factors contribute to the etiology and pathogenesis of AIS. Several studies have shown low bone mass and osteopenia in AIS patients.^\[[@R31],[@R35],[@R36]\]^ The etiology and pathogenesis of AIS remain poorly understood. Numerous studies have indicated significant linkages through genetic analysis, suggesting that AIS might be a complex genetic disorder influenced by multiple genes.^\[[@R28]\]^ The roles of the *VDR* gene have been verified by a genome-wide study, and this gene encodes a protein that affects the vitamin D endocrine system, for example, by regulating calcium and phosphate absorption from food.^\[[@R25]\]^ In addition, VDR is considered to play important roles in various systems, such as the immune, neural, epithelial, and skeletal muscular systems.^\[[@R37]\]^ Moreover, importance of *VDR* gene polymorphisms is increasing in susceptibility to many diseases, such as systemic lupus erythematosus,^\[[@R38],[@R39]\]^ osteoporosis,^\[[@R40],[@R41]\]^ and rheumatoid arthritis (RA).^\[[@R42],[@R43]\]^

Thus far, several single nucleotide polymorphisms (SNPs) of the *VDR* gene at or near the 3'UTR region (TaqI, BsmI, and ApaI) and exon 2 (FokI) have been identified.^\[[@R44]\]^ The TaqI, BsmI, and ApaI polymorphisms are named T-t, B-b, A-a, and F-f, respectively.^\[[@R31]\]^ These polymorphisms can regulate the stability and vitality of VDR mRNA.^\[[@R25]\]^ Therefore, it is well established that the *VDR* gene plays important roles in the etiology of many metabolic diseases, and more diseases have been found to be significantly associated with *VDR* gene polymorphisms. Bermúdez-Morales et al^\[[@R45]\]^ reported a correlation between the VDR TaqI and BsmI polymorphisms and multiple sclerosis in Mexican adults. One study demonstrated the association between VDR polymorphisms and the risk of systemic lupus erythematosus in a Chinese population.^\[[@R46]\]^ Another study suggested that VDR polymorphisms were related to aggressive bone loss in women with RA and that VDR genotypes might be a predictor for screening for bone loss in women with early-stage RA.^\[[@R47]\]^ A systematic review and meta-analysis showed that VDR polymorphisms played a protective role in intervertebral disc degeneration.^\[[@R48]\]^

As associations have been observed between *VDR* gene polymorphisms and many diseases, more attention has been focused on whether *VDR* gene polymorphisms also play important roles in the risk of AIS.^\[[@R29],[@R31]--[@R34]\]^ However, the results have been conflicting. To the best of our knowledge, no systematic assessment of the relationship between *VDR* gene polymorphisms (BsmI rs1544410 and ApaI rs7975232 polymorphism) and AIS risk has been conducted. Thus, we executed a meta-analysis to estimate the associations of the BsmI rs1544410 or ApaI rs7975232 gene polymorphisms with AIS risk.

BsmI consists of 2 nucleotide variants A-G in intron 8 of the *VDR* gene. Morriso et al^\[[@R49]\]^ first reported that these VDR alleles might predict BMD, suggesting that BsmI was a key factor for BMD and that the B allele of VDR was associated with low BMD. Other studies showed similar results, suggesting a tendency for lower bone mass with the B allele in various ethnicities.^\[[@R37],[@R50],[@R51]\]^ Regarding the BsmI polymorphism, studies concluded that the Bb genotype and B variant appeared to lead to low bone density and delayed menstruation in comparison to the b allele,^\[[@R52],[@R53]\]^ and these characteristics of low bone density and delayed menstruation are significantly associated with progressive spinal curvature.^\[[@R54]\]^ Xia et al^\[[@R29]\]^ found that the frequencies of the B allele and the Bb genotype were higher in the AIS group than in controls in the Chinese population and that young Chinese AIS patients with the Bb genotype had a risk of low bone density and delayed menarche, which was also found to be associated with the progressive process of AIS. Chen et al^\[[@R32]\]^ reported a higher frequency of the Bb genotype in an AIS group than in the control group among Asian young women, but there was no significant difference between ApaI and BsmI and BMD in the lumbar spine or femoral neck in AIS.^\[[@R32]\]^ The study by Wang et al^\[[@R33]\]^ showed that there were higher frequencies of the BsmI Bb genotype and B allele in AIS in a Chinese population. However, Yilmaz et al^\[[@R34]\]^ did not find any differences in the distribution of BsmI genotypes between AIS cases and controls in Caucasian populations. In our meta-analysis study, a significant relationship between the allele and genotype frequencies of the BsmI polymorphism and AIS patients was observed in the overall population. In the subgroup analysis of ethnicity, our study showed that the VDR BsmI polymorphisms were significantly associated with susceptibility to AIS in the Asian population, which was consistent with 4 studies^\[[@R29],[@R31]--[@R33]\]^ that we included. However, no significant associations were observed in Caucasian populations. In our opinion, the small sample size in the study by Yilmaz et al ^\[[@R34]\]^ might contribute to these conflicting results. Another important contributor to significant differences in Asian and Caucasian populations was ethnicity. Each ethnicity has its specific gene background that might have a different role in the risk and pathogenesis of AIS. Therefore, the relationship between VDR BsmI and susceptibility to AIS in Caucasian populations should be further studied.

Similar to BsmI, the ApaI polymorphism is located in the 3' end of the *VDR* gene.^\[[@R55]\]^ One study demonstrated that the recessive "aa" allele of ApaI might be correlated with a higher level of vitamin D in serum.^\[[@R56]\]^ Wu et al^\[[@R41]\]^ reported that there were significant differences in Ward triangle BMD among each genotype of VDR, in which the aa allele was found in the lower BMD group among a total of 378 patients (normal BMD, 234 cases; decreased BMD, 65 cases; osteoporosis with osteoporotic fracture, 79 cases). This finding suggests that ApaI plays a core role in osteoporosis risk in a Chinese population. However, another study indicated no significant difference between the frequency of ApaI in the control and case groups in a Caucasian population, suggesting no association between the ApaI allele and the osteoporotic population.^\[[@R40]\]^ The study by Xia et al^\[[@R29]\]^ indicated that the main distribution of the ApaI allele was "aa" with rare distribution of "AA," but no differences were observed between controls and AIS patients. Another 2 studies^\[[@R32],[@R33]\]^ concluded the same results. Our data showed a significant association between ApaI polymorphism and susceptibility to AIS in an Asian population, and the "aa" allele was a protective factor. This finding is inconsistent with that of the studies^\[[@R29],[@R32],[@R33]\]^ included in our meta-analysis. In our opinion, sample size, genotyping techniques, and selection biases might be important contributors to this difference. Compared with the results of these studies,^\[[@R29],[@R32],[@R33]\]^ our results provide a more exact conclusion, as the sample size and statistical power were expanded in our meta-analysis, which could give us a better understanding of the role of the VDR ApaI polymorphism in AIS etiology. In addition, whether the VDR ApaI polymorphism plays a key role in AIS etiology in either Caucasian or overall populations remains unclear, as no articles studying the relationship between ApaI rs7975232 polymorphism and AIS risk were found in our database search. This aspect needs to be further studied.

Although this was a comprehensive analysis of the relationship between BsmI rs1544410 or ApaI rs7975232 and AIS risk, there are still some limitations that should be addressed. First, only 5 studies were included in our study. One study was excluded in our meta-analysis due to unavailable data, despite numerous attempts to contact authors requesting the original data. Second, the sample sizes were relatively small in all the studies, which might lead to contrasting results and influence the conclusions. Third, only 1 study was conducted to explore the relationship between VDR BsmI and AIS risk in a Caucasian population, and this may not be sufficient to draw a convincing conclusion on overall populations. Lastly, we did not perform an adjusted analysis in our study because of insufficient data, and this is a limitation that should not be ignored.

In recent years, genetic analyses of human diseases with quantitative traits have primarily focused on identifying common variants through GWAS, and many novel susceptibility genes implicating specific biological pathways have been identified. The successes of GWAS for common diseases have provided critical insights into the contribution of genetic variants to common diseases and stimulated interest in follow-up studies of disease etiologies. However, there are still some limitations in GWAS that we should not neglect. Despite the discovery of multiple validated SNPs for diseases, GWAS have only revealed a small proportion of the genetic components of complex diseases. In addition, although GWAS have identified numerous SNPs that are associated with several complex diseases or traits, most GWAS-identified SNPs are located in noncoding regions and serve as markers for all SNPs in the same haplotype block. A meta-analysis is a statistical analysis that combines the results of multiple scientific studies. However, there are still many problems with a meta-analysis, such as publication bias, heterogeneity, and the omission of gene--gene and gene--environment interactions. Although there are many shortcomings of a meta-analysis, our study was the first such study that was conducted to explore the associations between the VDR BsmI rs1544410 and ApaI rs7975232 polymorphisms and AIS risk. This study has provided us with information that has furthered our understanding of AIS etiology.

6. Conclusion
=============

The VDR BsmI polymorphism was significantly associated with AIS susceptibility in the overall and Asian populations, while the VDR ApaI polymorphism only played a key role in AIS etiology and development in Asian populations.
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